Concepedia

Eyal C. Attar

EC

Statistics

Publications

91

Citations

10.2K

H-Index

47

Active since

1997

Affiliations

Massachusetts General Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

The University of Texas MD Anderson Cancer Center

Memorial Sloan Kettering Cancer Center

Eyal C. Attar is an author at Massachusetts General Hospital specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1997–2023

91

Publications

91

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Benjamin L. Ebert, Jennifer Pretz, Jocelyn Bosco et al. · Nature · 2008 · 910 citations · Full text

Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 436 citations · Full text

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 363 citations · Full text

Acute Myeloid Leukemia

Margaret R. O'Donnell, Camille N. Abboud, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2012 · 326 citations · Full text

, , +14

1–5 of 91